Page last updated: 2024-09-05

4-(3-(biotinylaminohexamethylenaminocarbonyl)propanoylaminomethyl)-2-methyl-1,3-dithiolane-2-yl-(ala(7))phalloidin and Angiogenesis, Pathologic

4-(3-(biotinylaminohexamethylenaminocarbonyl)propanoylaminomethyl)-2-methyl-1,3-dithiolane-2-yl-(ala(7))phalloidin has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diglio, CA; Honn, KV; Porter, A; Renaud, C; Stojakovic, S; Tang, DG1

Other Studies

1 other study(ies) available for 4-(3-(biotinylaminohexamethylenaminocarbonyl)propanoylaminomethyl)-2-methyl-1,3-dithiolane-2-yl-(ala(7))phalloidin and Angiogenesis, Pathologic

ArticleYear
12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis.
    Biochemical and biophysical research communications, 1995, Jun-15, Volume: 211, Issue:2

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Biotin; Cell Division; Cells, Cultured; Clone Cells; DNA; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Kinetics; Mice; Microcirculation; Mitogens; Neovascularization, Pathologic; Phalloidine; Pulmonary Circulation; Thymidine; Wound Healing

1995